IQVIA HOLDINGS INC. IQV

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $236.69
Market Cap $40.32B
P/E Ratio 30.19
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.9% YoY
$16.31B
3-Yr CAGR: 4.2%
Net Income ↓-0.9% YoY
$1.36B
Net Margin: 8.3%
Free Cash Flow ↓-0.6% YoY
$2.13B
FCF Yield: 5.27%
EPS (Diluted) ↑4.7% YoY
$7.84
Basic: $7.91
Return on Equity Efficiency
20.9%
ROA: 21.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (IQV)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $6,878.0M $6,734.0M $115.0M $0.76 $860.0M $696.0M
FY 2017 $9,739.0M +41.6% $9,393.0M $1,309.0M +1,038.3% $5.88 +673.7% $970.0M $601.0M -13.6%
FY 2018 $10,412.0M +6.9% $9,998.0M $259.0M -80.2% $1.24 -78.9% $1,254.0M $795.0M +32.3%
FY 2019 $11,088.0M +6.5% $10,641.0M $191.0M -26.3% $0.96 -22.6% $1,417.0M $835.0M +5.0%
FY 2020 $11,359.0M +2.4% $10,943.0M $279.0M +46.1% $1.43 +49.0% $1,959.0M $1,343.0M +60.8%
FY 2021 $13,874.0M +22.1% $13,499.0M $966.0M +246.2% $4.95 +246.2% $2,942.0M $2,302.0M +71.4%
FY 2022 $14,410.0M +3.9% $13,994.0M $1,091.0M +12.9% $5.72 +15.6% $2,260.0M $1,586.0M -31.1%
FY 2023 $14,984.0M +4.0% $14,312.0M $1,358.0M +24.5% $7.29 +27.4% $2,149.0M $1,500.0M -5.4%
FY 2024 $15,405.0M +2.8% $14,735.0M $1,373.0M +1.1% $7.49 +2.7% $2,716.0M $2,139.0M +42.6%
FY 2025 $16,310.0M +5.9% $15,581.0M $1,360.0M -0.9% $7.84 +4.7% $2,654.0M $2,126.0M -0.6%
$

Valuation

Market Price $236.69
Market Cap $40.32B
Enterprise Value $54.07B
P/E Ratio 30.19
P/B Ratio 6.07
FCF Yield 5.27%
Dividend Yield N/A
Shares Outstanding 166,900,000
%

Profitability & Margins

Gross Margin 95.53%
Operating Margin 13.38%
Net Margin 8.34%
Return on Equity (ROE) 20.91%
Return on Assets (ROA) 21.76%
Asset Turnover 2.61x
Revenue 3-Yr CAGR 4.21%
🛡️

Financial Health & Liquidity

Current Ratio 2.10
Cash Ratio 0.67
Debt / Equity 2.418
Debt / Assets 2.516
Cash & Equivalents $1.98B
Total Debt $15.72B
Book Value / Share $38.96
💧

Cash Flow Efficiency

Operating Cash Flow $2.65B
Capital Expenditures (CapEx) $528.00M
Free Cash Flow $2.13B
OCF / Revenue 16.27%
FCF / Revenue 13.03%
FCF 3-Yr CAGR 10.26%
🏷️

Per Share Metrics

EPS (Diluted) $7.84
EPS (Basic) $7.91
Dividends / Share N/A
Book Value / Share $38.96
EPS YoY Growth 4.67%
🏛️

Balance Sheet (FY 2025)

Total Assets $6.25B
Total Liabilities $2.97B
Stockholders' Equity $6.50B
Current Assets $6.25B
Current Liabilities $2.97B